Analystreport

Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre